Gregory Kalemkerian

60 questions about SCLC with Dr. Gregory Kalemkerian Part 1

In this episode, Dr. Nune Karapetyan speaks with Dr. Gregory Kalemkerian, a leading authority in thoracic oncology, who answers 60 rapid-fire questions about small cell lung cancer (SCLC). From the basics of what makes SCLC unique to the most recent clinical trial data and treatment breakthroughs, this conversation provides a clear, comprehensive overview of the disease.

Key points covered:

  • Why SCLC is so aggressive and difficult to detect early.
  • The role of smoking in shaping global incidence trends.
  • Advances with immunotherapy, tarlatumab, and lurbinectadine.
  • Insights from the Adriatic trial and the evolving use of PCI.
  • Challenges in relapse therapy, biomarkers, and resistance.